SEC Form 4
Summit Therapeutics Inc. (SMMT) insider trading
In the 12 months to Nov 15, 2026, 3 SMMT insiders reported open-market purchases of $103.6M across 5 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $103.6M
- 5 filings
Who traded SMMT, and when
- Purchase
SMMT daily close from Nov 17, 2025 to Nov 13, 2026, between $12.43 and $26.38, last $14.15. 0 sale and 5 purchase filings by 3 insiders, marked at their filing dates. Mahkam Zanganeh, Co-Chief Executive Officer: bought $51.4M across 2 filings, first filed Jun 4, 2026, last Jun 12, 2026. Robert W. Duggan, Co-Chief Executive Officer: bought $51.4M across 2 filings, first filed Jun 4, 2026, last Jun 12, 2026. Manmeet Singh Soni, COO and CFO: bought $722.3K across 1 filing, first filed Jun 4, 2026, last Jun 4, 2026.
Largest mark · tap a row for others
Mahkam Zanganeh · Co-Chief Executive Officer
Purchase $49,987,200
3,810,000 shares at $13.12 avg
Filed Jun 12, 2026
Close on filing date $14.01
Mahkam Zanganeh · Co-Chief Executive Officer
Co-Chief Executive Officer
$51.4M boughtRobert W. Duggan · Co-Chief Executive Officer
Co-Chief Executive Officer
$51.4M boughtManmeet Singh Soni · COO and CFO
COO and CFO
$722.3K boughtOpen-market trades
5 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Mahkam Zanganeh | Co-Chief Executive Officer | — | $51.4M | 2 | — | |
| Robert W. Duggan | Co-Chief Executive Officer | — | $51.4M | 2 | — | |
| Manmeet Singh Soni | COO and CFO | — | $722.3K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Robert W. Duggan Co-Chief Executive Officer | Purchase | 3,810,000 | $13.12 | $50.0M | 573,883,879 | |
traded | Mahkam Zanganeh Co-Chief Executive Officer | Purchase | 3,810,000 | $13.12 | $50.0M | 573,883,879 | |
traded | Robert W. Duggan Co-Chief Executive Officer | Purchase | 100,000 | $14.60 | $1.5M | 25,824,474 | |
traded | Mahkam Zanganeh Co-Chief Executive Officer | Purchase | 100,000 | $14.60 | $1.5M | 25,824,474 | |
traded | Manmeet Singh Soni COO and CFO | Purchase | 50,000 | $14.45 | $722.3K | 3,123,603 |
GET /stocks/filings/vX/form-4?tickers=SMMT&filing_date.gte=2025-11-15&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"SMMT"
],
"issuer_cik": "0001599298",
"owner_cik": "0001055919",
"accession_number": "0001055919-26-000007",
"form_type": "4",
"filing_date": "2026-06-12",
"period_of_report": "2026-06-12",
"issuer_name": "Summit Therapeutics Inc.",
"issuer_trading_symbol": "SMMT",
"owner_name": "DUGGAN ROBERT W",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "Co-Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-06-12",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 3810000,
"transaction_price_per_share": 13.12,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 573883879,
"transaction_value": 49987200,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"SMMT"
],
"issuer_cik": "0001599298",
"owner_cik": "0001507650",
"accession_number": "0001507650-26-000007",
"form_type": "4",
"filing_date": "2026-06-12",
"period_of_report": "2026-06-12",
"issuer_name": "Summit Therapeutics Inc.",
"issuer_trading_symbol": "SMMT",
"owner_name": "Zanganeh Mahkam",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "Co-Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-06-12",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 3810000,
"transaction_price_per_share": 13.12,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 573883879,
"transaction_value": 49987200,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "By Spouse",
"footnotes": [
{
"id": "F1",
"description": "The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 1 record
- Grants and awards1 record
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Summit Therapeutics Inc.'s CEO sold stock?
No. Mahkam Zanganeh and Robert W. Duggan (CEOs) made no open-market sales filed as CEO in the last 12 months.
How current is SMMT’s insider data?
These are SMMT Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track SMMT insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for SMMT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.